Post by
davewho on Jun 08, 2021 2:24pm
CARE
we can probably be quite sure the researchers at Care are qualified to do a direct comparison of Aristotle and Galleri and how effective the tests are and the differences. Care does medical studies maybe they would undertake such a study. Ask Grail to pay for it. Which is why we need to see the Care deal close asap. It would tell us 2 things. Aristotle has validity and that Care is willing to use and sell it and that they are unphased by the much larger Grail offering Galleri.
I suspect Care already did the comparison before the LOI was signed.